Projects per year
Personal profile
Biography
Dr Ing Soo Tiong is a clinical haematologist consulting from Eastern Haematology Oncology Group.
He graduated from the University of Otago and completed his Basic Physician Training in Dunedin, New Zealand. He joined Alfred Hospital (2016) as the Leukaemia Fellow, awarded the HSANZ New Investigator Scholarship for 2017, and completed Haematology Advance Training in 2017 with dual Fellowships of the Royal Australasian College of Physicians and the Royal College of Pathologists of Australasia.
He is undertaking a part-time research higher degree at Alfred Hospital/Monash University. His interests are myeloid malignancies (acute leukaemias, myelodysplastic syndromes and myeloproliferative neoplasms), but would welcome any malignant and non-malignant haematological condition. He is also active in clinical trial developments, working to translate scientific breakthroughs and seek treatment options for patients he treats.
Ing-Soo is the medical lead for Acute Lymphoblastic Leukaemia at the Austin Hospital.
Other appointments: Alfred Hospital (Clinical Haematologist), Peter MacCallum Cancer Centre (Laboratory Haematologist).
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research area keywords
- Haematology
- Myeloid malignancies
- Acute leukaemia
- Myelodysplasia
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A Phase 1b, multicenter, open-label platform study of select drug combinations in adult patients with lower risk (very low, low, or intermediate risk) myelodysplastic syndrome
Tiong, I. S. & Kennedy, N.
1/04/21 → 31/12/25
Project: Research
-
A phase 2 study of venetoclax in combination with low-dose cytarabine in relapsing acute myeloid leukemia.
Wei, A., Tiong, I. S., Reynolds, J. & Kennedy, N.
22/09/19 → 31/12/24
Project: Research
-
A Phase 3, Open-label, Randomized Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) versus Epoetin Alfa for the Treatment of Anemia due to IPSS-R Very Low, Low or Intermediate Risk Myelodysplastic Syndromes (MDS) in ESA Naive Subjects who require Red Blood Cell Transfusions.
Tiong, I. S. & Kennedy, N.
15/07/19 → 31/12/24
Project: Research
-
Establishing a Monash Partners national reference centre for molecular monitoring of residual disease (MRD) in acute myeloid leukaemia
Wei, A., Ivey, A., Fleming, S. A., Tiong, I. S., McManus, J. & Ting, S.
1/01/17 → 31/12/19
Project: Research
-
Outcomes of non-myeloablative allogeneic stem cell transplant in older patients with acute myeloid leukaemia in first remission
Nguyen, P. C., Manos, K., Fong, C. Y., Schwarer, A. P., Tiong, I. S., Wei, A. H., Kliman, D. & Curtis, D. J., Nov 2021, In: Internal Medicine Journal. 51, 11, p. 1954-1958 5 p.Research output: Contribution to journal › Article › Research › peer-review
-
Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT): A Phase Ib Dose-Escalation Study of Venetoclax Combined With Modified Intensive Chemotherapy
Chua, C. C., Roberts, A. W., Reynolds, J., Fong, C. Y., Ting, S. B., Salmon, J. M., MacRaild, S., Ivey, A., Tiong, I. S., Fleming, S., Brown, F. C., Loo, S., Majewski, I. J., Bohlander, S. K. & Wei, A. H., 20 Oct 2020, In: Journal of Clinical Oncology. 38, 30, p. 3506-3517 12 p.Research output: Contribution to journal › Article › Research › peer-review
41 Citations (Scopus) -
Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML
DiNardo, C. D., Tiong, I. S., Quaglieri, A., MacRaild, S., Loghavi, S., Brown, F. C., Thijssen, R., Pomilio, G., Ivey, A., Salmon, J. M., Glytsou, C., Fleming, S. A., Zhang, Q., Ma, H., Patel, K. P., Kornblau, S. M., Xu, Z., Chua, C. C., Chen, X., Blombery, P. & 9 others, , 12 Mar 2020, In: Blood. 135, 11, p. 791-803 13 p.Research output: Contribution to journal › Article › Research › peer-review
153 Citations (Scopus) -
Chromosomal abnormalities and prognosis in NPM1-mutated acute myeloid leukemia: A pooled analysis of individual patient data from nine international cohorts
Angenendt, L., Röllig, C., Montesinos, P., Martínez-Cuadrón, D., Barragan, E., García, R., Botella, C., Martínez, P., Ravandi, F., Kadia, T., Kantarjian, H. M., Cortes, J., Juliusson, G., Lazarevic, V., Höglund, M., Lehmann, S., Recher, C., Pigneux, A., Bertoli, S., Dumas, P. Y. & 25 others, , 10 Oct 2019, In: Journal of Clinical Oncology. 37, 29, p. 2632-2642 11 p.Research output: Contribution to journal › Article › Research › peer-review
Open AccessFile29 Citations (Scopus) -
Combining BH3-Mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemia
Moujalled, D. M., Pomilio, G., Ghiurau, C., Ivey, A., Salmon, J., Rijal, S., Macraild, S., Zhang, L., Teh, T. C., Tiong, I. S., Lan, P., Chanrion, M., Claperon, A., Rocchetti, F., Zichi, A., Kraus-Berthier, L., Wang, Y., Halilovic, E., Morris, E., Colland, F. & 7 others, , 1 Apr 2019, In: Leukemia. 33, a, p. 905-917 13 p.Research output: Contribution to journal › Article › Research › peer-review
Open AccessFile84 Citations (Scopus)